« | Home | Recent Comments | Categories | »

The Anti-Science Streak in Federal Marijuana Policy

Posted on May 17th, 2012 at 15:36 by Paul Jay in category: News -- Write a comment

[Quote]:

Dr. Jody Corey-Bloom, director of the Multiple Sclerosis Center at UC San Diego, recently helped run a study that provided multiple sclerosis patients with either a marijuana joint or a placebo that looked, smelled, and tasted like marijuana. After smoking whichever substance they were given, patients were tested to see if it reduced their muscle spasticity — an affliction, common to MS patients, that causes painful, uncontrollable spasms of the extremities. Spasticity was unaffected among the placebo patients but dropped 30 percent on average among the patients given real marijuana. The side effects? “Smoking caused fatigue and dizziness in some users,” says Reuters, “and slowed down people’s mental skills soon after they used marijuana.”

The UC San Diego study is just the latest to suggest that marijuana has some medical benefits. Sixteen states, thousands of doctors, and tens of thousands of sick people concur in that judgment. It is dramatized by the personal testimony of sick people who are offered much more powerful drugs, but nevertheless insistthat consuming marijuana was most effective at helping them. (Don’t miss the video at the top of this post, as powerful a testimonial for medical marijuana as you’ll find.)

Marijuana is nevertheless classified under the Controlled Substances Act as a Schedule One drug. Under the law, drugs placed in that category must meet all of the following criteria (emphasis added):

  • The drug or other substance has a high potential for abuse.
  • The drug or other substance has no currently accepted medical use in treatment in the United States.
  • There is a lack of accepted safety for use of the drug or other substance under medical supervision
  1. I think there’s another item of importance:

    * The drug is sold in direct competition to the prevailing pharmaceutical industry’s products.

  2. * The drug is sold in direct competition to the prevailing law enforcement and incarceration industries

previous post: Cartoons

next post: Obama vs Romney